JESSICA KNIGHT: Open Payments
NPI 1568645042 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,030 in 37 payments from 12 companies in 2025. Trend: 2023 $653 · 2024 $609 · 2025 $1,030
Food & beverage: $1,030
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 4 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $201 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| Vifor Pharma, Inc. | 1 | $120 |
| Ardelyx, Inc. | 3 | $98 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Travere Therapeutics, Inc. | 4 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
Products named: Vafseo, Kerendia, FARXIGA, Veltassa, IBSRELA, BENLYSTA, JARDIANCE, FUROSCIX.
Industry payments across NM — which companies pay providers there.
